Dean JD - Search Results

1

The pharmacokinetics of five pre-mixed combinations of 'short-' and 'intermediate-acting' (NPH) insulins in healthy subjects following subcutaneous administration.

Owens DR, Jones AL, Dolben J, Dean JD, Petocz P, Coates PA, Luzio SD. Owens DR, et al. Among authors: dean jd. Diabetes Res. 1993;22(2):77-86. Diabetes Res. 1993. PMID: 8205740 Clinical Trial.

2

Apolipoprotein and lipid ratios in treated non-insulin dependent diabetics.

Dean JD, Owens DR, Matthews SB. Dean JD, et al. Diabetes Res. 1990 Sep;15(1):21-5. Diabetes Res. 1990. PMID: 2132196

3

Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.

Vora JP, Owens DR, Dolben J, Atiea JA, Dean JD, Kang S, Burch A, Brange J. Vora JP, et al. Among authors: dean jd. BMJ. 1988 Nov 12;297(6658):1236-9. doi: 10.1136/bmj.297.6658.1236. BMJ. 1988. PMID: 3145064 Free PMC article. Clinical Trial.

4

Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus.

Vora JP, Dolben J, Dean JD, Thomas D, Williams JD, Owens DR, Peters JR. Vora JP, et al. Among authors: dean jd. Kidney Int. 1992 Apr;41(4):829-35. doi: 10.1038/ki.1992.127. Kidney Int. 1992. PMID: 1513105 Free article.

5

Cholesterol rich apo B containing lipoproteins and smoking are independently associated with macrovascular disease in normotensive NIDDM patients.

Dean JD, Matthews SB, Dolben J, Carolan G, Luzio S, Owens DR. Dean JD, et al. Diabet Med. 1994 Oct;11(8):740-7. doi: 10.1111/j.1464-5491.1994.tb00347.x. Diabet Med. 1994. PMID: 7851067

6

The effect of acipimox in patients with type 2 diabetes and persistent hyperlipidaemia.

Dean JD, McCarthy S, Betteridge DJ, Whately-Smith C, Powell J, Owens DR. Dean JD, et al. Diabet Med. 1992 Aug-Sep;9(7):611-5. doi: 10.1111/j.1464-5491.1992.tb01855.x. Diabet Med. 1992. PMID: 1511566 Clinical Trial.

7

Hyperinsulinaemia and microvascular angina ("syndrome X").

Dean JD, Jones CJ, Hutchison SJ, Peters JR, Henderson AH. Dean JD, et al. Lancet. 1991 Feb 23;337(8739):456-7. Lancet. 1991. PMID: 1671472

8

Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM.

Bhatnagar D, Durrington PN, Kumar S, Mackness MI, Dean J, Boulton AJ. Bhatnagar D, et al. Diabetes. 1995 Apr;44(4):460-5. doi: 10.2337/diab.44.4.460. Diabetes. 1995. PMID: 7698516 Clinical Trial.

9

Treatment of dyslipoproteinaemia in diabetes mellitus.

Dean JD, Durrington PN. Dean JD, et al. Diabet Med. 1996 Apr;13(4):297-312. doi: 10.1002/(SICI)1096-9136(199604)13:4<297::AID-DIA82>3.0.CO;2-Q. Diabet Med. 1996. PMID: 9162604 Review.

10

Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.

Julier K, Mackness MI, Dean JD, Durrington PN. Julier K, et al. Among authors: dean jd. Diabet Med. 1999 May;16(5):415-23. doi: 10.1046/j.1464-5491.1999.00089.x. Diabet Med. 1999. PMID: 10342342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters